Stifel Upgrades RXO to Buy, Announces $22 Price Target

Benzinga Newsdesk www.benzinga.com Positive 67.9%

Neg 0% Neu 0% Pos 67.9%

Stifel analyst J. Bruce Chan upgrades RXO (NYSE:RXO) from Hold to Buy and announces $22 price target.

Comments

No comments yet. Be the first!